Comprehensive Analysis of the Polyether Antibiotics Market Share 2024: Emerging Trends, Growth Drivers, and Future Opportunities in Veterinary and Agricultural Applications | Ceva Sante Animale, and Dechra Pharmaceuticals PLC

Market Overview:

Polyether antibiotics are used to treat bacterial infections mainly in food animals. These products kill bacteria by disrupting their cell membranes.

Market Dynamics:

Polyether antibiotics work by disrupting bacterial cell membranes through their complex polyether structures. The growth of the global polyether antibiotics market is majorly driven by the rising prevalence of bacterial infections globally. It is estimated that around 700,000 people die due to antibiotic resistance each year worldwide. Furthermore, excessive use of antibiotics in clinical practices and livestock farming has led to the development of drug-resistant bacteria. This factor is also expected to fuel demand for polyether antibiotics during the forecast period. Polyether antibiotics show efficacy against multi-drug resistant (MDR) bacterial strains. This advantage is further expected to support market growth between 2024 and 2031.

Request Sample Copy of the Report at: - https://www.coherentmarketinsights.com/insight/request-sample/2305

List of TOP Players in Market Report are: -

◘ Zoetis Inc.
◘ Elanco Animal Health Inc.
◘ Hester Biosciences Limited
◘ Huvepharma AD
◘ Ceva Sante Animale
◘ Dechra Pharmaceuticals PLC.

Note: Major Players are sorted in no particular order.

Market Detailed Segmentation:

By Drug:

Lasalocid
Monesin
Salinomycin
Narasin
Others

By Application:

Coccidiosis
Growth Promotion in Cattles
Others

Increasing incidence rate of infectious disease across the globe acts as a major driver for polyether antibiotics market

The rising prevalence of infectious diseases such as pneumonia, urinary tract infections, diarrhea, infections by antibiotic-resistant pathogens etc across the globe is acting as one of the major driver for the growth of polyether antibiotics market. As per World Health Organization estimates, infectious diseases account for approximately 17 million deaths globally every year which is quite high. The increasing resistance to traditional antibiotics by various infectious pathogens has augmented the demand for alternative and novel antibiotics like polyether antibiotics. Polyether antibiotics have several advantages over traditional antibiotics such as broad spectrum activity, minimal side effects and low resistance development by microbes which makes them an attractive therapeutic option for treating multi-drug resistant infections.

Growing meat consumption worldwide is boosting the polyether antibiotics demand

Polyether antibiotics are widely used as feed additives in livestock production owing to their anti-microbial and growth promoting properties. The rapid growth in meat consumption especially poultry meat across the world is directly influencing the polyether antibiotics market growth. As per Food and Agriculture Organization (FAO), global meat production has more than quadrupled since 1960. Countries like China, Brazil, United States are among the top meat consuming nations globally. Inclusion of polyether antibiotics in animal feed improves digestion, nutrient absorption, weight gain and feed conversion efficiency in animals which further increases meat production. However, concerns regarding antimicrobial resistance stemming from non-therapeutic use of antibiotics in livestock may restrain the polyether antibiotics demand to some extent in feed additive segment.

Buy This Premium Report and Get Upto 25 % OFF: https://www.coherentmarketinsights.com/insight/buy-now/2305

Stringent regulatory framework imposed on antibiotic use in animal feed acts as a major market restraint

Several regulatory bodies around the globe are increasingly imposing stringent restrictions on the use of antibiotics as growth promoters in animal feed due to rising antibiotic resistance concerns. For example, in EU countries, polyether ionophore antimicrobials including monensin and salinomycin were banned in 2006 for uses other than therapeutic and prophylactic purposes in animal husbandry. Similarly, in USA, FDA issued guidance for the industry in 2013 to phase out certain antibiotic classes from animal feed for growth promotion and feed efficiency. Such stringent regulatory policies discourage the non-therapeutic use of polyether antibiotics which negatively impacts the market growth. The regulatory pressure is mounting on demonstrating safety, efficacy and public health benefits for continued approval of antibiotics as feed additives.

Rising focus on development of synergistic antibiotic combinations opens up new market opportunities

Growing bacterial resistance towards commonly used antibiotics has shifted the focus of drug makers towards development of synergistic antibiotic combinations with enhanced efficacy. Compared to monotherapy, combination therapies are able to broaden the spectrum of activity, delay resistance development and achieve higher bacterial clearance. Polyether ionophores exhibit synergism when combined with other antibiotics and this property is being leveraged for designing novel antibiotic formulations. For instance, monensin in combination with beta-lactams and aminoglycosides improves efficacy against multi-drug resistant gram-positive and gram-negative pathogens. Several clinical trials are underway to evaluate polyether antibiotic combinations for diverse infections indicating significant market potential over the forecast period.

Shift towards polyether ionophores from conventional antibiotics expected to be a major trend

There is a clear trend of replacing conventional antibiotics with polyether ionophores in both human therapeutics and animal feed applications. Polyether ionophores offer some clinically relevant advantages including lack of antibacterial cross-resistance and minimal effects on normal microflora. With rising antibiotic resistance, polyether ionophores with their unique mechanism of action are emerging as an important substitute. Also, removal of growth-promoting antibiotics from livestock feed in several countries has boosted the use of alternatives like polyether ionophores as they improve gut health and animal productivity. Leading manufacturers are investing in clinical efficacy and safety studies for expanded therapeutic indications of polyether ionophores which is likely to drive their adoption and gain larger market share compared to traditional antibiotics.

Furthermore, the years considered for the study are as follows:

Historical data - 2016-2022
The base year for estimation - is 2022
Estimated Year - 2024
Forecast period** - 2024 to 2031

This Polyether Antibiotics Market Research/Analysis Report Contains Answers to your following Questions:

◈What are the current global trends in the Polyether Antibiotics market, and will the market experience an increase or decrease in demand in the upcoming years?

◈ What is the expected demand for various product types within the Polyether Antibiotics market, and what are the emerging Market applications and trends?

◈ What are the projections for the global Polyether Antibiotics Market in terms of capacity, production, production value, cost, profit, market share, supply, consumption, import, and export?

◈ How will strategic developments shape the Market trajectory in the medium to long term?

◈ What factors contribute to the final price of Polyether Antibiotics , and what are the raw materials used in its manufacturing?

◈ What is the market's growth potential, particularly with the increasing adoption of Polyether Antibiotics in mining?

◈ What is the current and 2022 value of the global market, and who are the leading companies in this market?

◈ What recent Market trends can be leveraged to create additional revenue streams?

◈ What entry strategies, economic impact mitigation measures, and marketing channels should be considered for the Polyether Antibiotics Market?

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/2305

Summarized Extracts from TOC of Market Study

Chapter 1 Polyether Antibiotics Introduction and Market Overview

1.1 Objectives of the Study

1.2 Overview of Polyether Antibiotics

1.3 Scope of The Study

1.3.1 Key Market Segments

1.3.2 Players Covered

1.3.3 COVID-19's impact on the Polyether Antibiotics industry

1.4 Methodology of The Study

1.5 Research Data Source

Chapter 2 Executive Summary

Chapter 3 Industry Chain Analysis

Chapter 4 Market, by Type

Chapter 5 Market, by Application

Chapter 6 Market Analysis by Regions

Chapter 7 North America Market Analysis by Countries

Chapter 8 Europe Polyether Antibiotics Market Analysis by Countries

Chapter 9 Asia Pacific Polyether Antibiotics Market Analysis by Countries

Chapter 10 Middle East and Africa Polyether Antibiotics Market Analysis by Countries

Chapter 11 South America Polyether Antibiotics Market Analysis by Countries

Chapter 12 Competitive Landscape

Chapter 13 Industry Outlook

Chapter 14 Market Forecast

Chapter 15 New Project Feasibility Analysis

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
JAPAN:+81-50-5539-1737
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.